Karlien Van Nerum
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Karlien Van Nerum has a total of 36 co-authors. Here are the top co-authors by number of shared publications:
- Adam Bendall
Epigenetics Programme, Babraham Institute, Cambridge, UK
1 shared publication Adrian Janiszewski
Department of Development and Regeneration, Leuven Stem Cell Institute, Leuven Institute for Single Cell Omics (LISCO), KU Leuven, Leuven, Belgium
1 shared publicationAlok Javali
Institute of Molecular Biotechnology of the Austrian Academy of Sciences, Vienna, Austria
1 shared publicationAmanda J. Collier
Epigenetics Programme, Babraham Institute, Cambridge, UK
1 shared publication- Amitesh Panda
Department of Development and Regeneration, KU Leuven, Leuven, Belgium
1 shared publication - Andrew A. Malcolm
Epigenetics Programme, Babraham Institute, Cambridge, UK
1 shared publication
Latest Publications
- Open Access
- 13 June 2022
- Published by Springer Nature in Nature Cell Biology
- Vol. 24 (6) , 858-871
Integrated multi-omics reveal polycomb repressive complex 2 restricts human trophoblast induction
Human naive pluripotent stem cells have unrestricted lineage potential. Underpinning this property, naive cells are thought to lack chromatin-based lineage barriers. However, this assumption has not been tested. Here we define the chromatin-associated proteome, histone post-translational modifications and transcriptome of human naive and primed pluripotent stem cells. Our integrated analysis reveals differences in the relative abundance and activities of distinct chromatin modules. We identify a strong enrichment of polycomb repressive complex 2 (PRC2)-associated H3K27me3 in the chromatin of naive pluripotent stem cells and H3K27me3 enrichment at promoters of lineage-determining genes, including trophoblast regulators. PRC2 activity acts as a chromatin barrier restricting the differentiation of naive cells towards the trophoblast lineage, whereas inhibition of PRC2 promotes trophoblast-fate induction and cavity formation in human blastoids. Together, our results establish that human naive pluripotent stem cells are not epigenetically unrestricted, but instead possess chromatin mechanisms that oppose the induction of alternative cell fates.
- 13 June 2022
- Published by Springer Nature in Nature Cell Biology
- Vol. 24 (6) , 858-871
Open AccessIntegrated multi-omics reveal polycomb repressive complex 2 restricts human trophoblast induction
Human naive pluripotent stem cells have unrestricted lineage potential. Underpinning this property, naive cells are thought to lack chromatin-based lineage barriers. However, this assumption has not been tested. Here we define the chromatin-associated proteome, histone post-translational modifications and transcriptome of human naive and primed pluripotent stem cells. Our integrated analysis reveals differences in the relative abundance and activities of distinct chromatin modules. We identify a strong enrichment of polycomb repressive complex 2 (PRC2)-associated H3K27me3 in the chromatin of naive pluripotent stem cells and H3K27me3 enrichment at promoters of lineage-determining genes, including trophoblast regulators. PRC2 activity acts as a chromatin barrier restricting the differentiation of naive cells towards the trophoblast lineage, whereas inhibition of PRC2 promotes trophoblast-fate induction and cavity formation in human blastoids. Together, our results establish that human naive pluripotent stem cells are not epigenetically unrestricted, but instead possess chromatin mechanisms that oppose the induction of alternative cell fates.